(NYSE: ANVS) Annovis Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.05%.
Annovis Bio's earnings in 2024 is -$43,017,369.On average, 3 Wall Street analysts forecast ANVS's earnings for 2024 to be -$32,983,587, with the lowest ANVS earnings forecast at -$47,125,005, and the highest ANVS earnings forecast at -$25,585,875.
In 2025, ANVS is forecast to generate -$24,019,393 in earnings, with the lowest earnings forecast at -$28,457,759 and the highest earnings forecast at -$19,581,027.